Healthcare provider profile · identity verified

Theodore M. Kelley, MD

Family Practice · LOCUST, NC · NPI 1154520823

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	651	174
Amlodipine Besylate	Amlodipine Besylate	587	158
Omeprazole	Omeprazole	496	130
Lisinopril	Lisinopril	358	100
Levothyroxine Sodium	Levothyroxine Sodium	298	77
Pravastatin Sodium	Pravastatin Sodium	287	76
Metformin Hcl Er	Metformin Hcl	270	75
Tramadol Hcl	Tramadol Hcl	270	69
Trazodone Hcl	Trazodone Hcl	263	71
Losartan Potassium	Losartan Potassium	258	70
Gabapentin	Gabapentin	255	56
Fluticasone Propionate	Fluticasone Propionate	249	93
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	231	38
Tamsulosin Hcl	Tamsulosin Hcl	209	55
Clonazepam	Clonazepam	201	48
Meloxicam	Meloxicam	197	52
Metoprolol Succinate	Metoprolol Succinate	197	52
Rosuvastatin Calcium	Rosuvastatin Calcium	197	55
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	192	46
Pantoprazole Sodium	Pantoprazole Sodium	183	48
Eliquis	Apixaban	176	38
Metformin Hcl	Metformin Hcl	173	42
Alprazolam	Alprazolam	169	31
Furosemide	Furosemide	148	46
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	139	32
Ozempic	Semaglutide	137	27
Hydrochlorothiazide	Hydrochlorothiazide	133	41
Escitalopram Oxalate	Escitalopram Oxalate	125	34
Sertraline Hcl	Sertraline Hcl	124	37
Albuterol Sulfate Hfa	Albuterol Sulfate	121	45
Simvastatin	Simvastatin	115	30
Venlafaxine Hcl Er	Venlafaxine Hcl	113	20
Metoprolol Tartrate	Metoprolol Tartrate	112	35
Clopidogrel	Clopidogrel Bisulfate	109	33
Doxycycline Hyclate	Doxycycline Hyclate	103	84
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	102	13
Prednisone	Prednisone	99	65
Tizanidine Hcl	Tizanidine Hcl	93	27
Duloxetine Hcl	Duloxetine Hcl	90	27
Mirtazapine	Mirtazapine	90	25
Fluoxetine Hcl	Fluoxetine Hcl	87	26
Potassium Chloride	Potassium Chloride	87	27
Celecoxib	Celecoxib	86	23
Zolpidem Tartrate	Zolpidem Tartrate	83	16
Esomeprazole Magnesium	Esomeprazole Magnesium	81	20
Montelukast Sodium	Montelukast Sodium	81	26
Carvedilol	Carvedilol	80	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	74	13
Xarelto	Rivaroxaban	73	13
Allopurinol	Allopurinol	71	21
Glipizide Er	Glipizide	71	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	68	18
Pioglitazone Hcl	Pioglitazone Hcl	68	18
Warfarin Sodium	Warfarin Sodium	68	19
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	67	20
Atenolol	Atenolol	67	15
Citalopram Hbr	Citalopram Hydrobromide	67	20
Temazepam	Temazepam	63	suppressed
Baclofen	Baclofen	62	14
Pregabalin	Pregabalin	60	14
Bupropion Xl	Bupropion Hcl	56	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	13
Lorazepam	Lorazepam	56	14
Azelastine Hcl	Azelastine Hcl	55	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	49	41
Ondansetron Hcl	Ondansetron Hcl	48	12
Fluconazole	Fluconazole	46	23
Triamcinolone Acetonide	Triamcinolone Acetonide	46	32
Diclofenac Sodium	Diclofenac Sodium	45	16
Testosterone Cypionate	Testosterone Cypionate	45	12
Estradiol	Estradiol	43	suppressed
Jardiance	Empagliflozin	42	suppressed
Glipizide	Glipizide	41	11
Mounjaro	Tirzepatide	41	suppressed
Tresiba Flextouch U-100	Insulin Degludec	41	suppressed
Januvia	Sitagliptin Phosphate	40	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	15
Lovastatin	Lovastatin	38	11
Cephalexin	Cephalexin	37	26
Glimepiride	Glimepiride	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	35	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	35	suppressed
Ezetimibe	Ezetimibe	35	12
Naproxen	Naproxen	35	suppressed
Famotidine	Famotidine	34	11
Farxiga	Dapagliflozin Propanediol	33	suppressed
Ipratropium Bromide	Ipratropium Bromide	33	14
Ventolin Hfa	Albuterol Sulfate	32	13
Nortriptyline Hcl	Nortriptyline Hcl	31	suppressed
Verapamil Er	Verapamil Hcl	31	suppressed
Ibuprofen	Ibuprofen	30	13
Synthroid	Levothyroxine Sodium	30	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Mupirocin	Mupirocin	29	20
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Ketoconazole	Ketoconazole	27	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Carisoprodol	Carisoprodol	26	suppressed
Omnipod 5 Dexg7g6 Pods (Gen 5)	Insulin Pump Cart,auto,bt,g6/7	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Primidone	Primidone	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Irbesartan	Irbesartan	23	suppressed
Diazepam	Diazepam	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Nitroglycerin	Nitroglycerin	20	12
Telmisartan	Telmisartan	20	suppressed
Topiramate	Topiramate	20	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Finasteride	Finasteride	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Nystatin	Nystatin	18	12
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	11
Methylprednisolone	Methylprednisolone	17	14
Nystop	Nystatin	17	suppressed
Cefdinir	Cefdinir	16	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Torsemide	Torsemide	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	12
Linzess	Linaclotide	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Brilinta	Ticagrelor	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Desloratadine	Desloratadine	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Digoxin	Digoxin	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error